{"id":"https://openalex.org/W4362619684","doi":"https://doi.org/10.1158/2767-9764.22545309","title":"Supplementary Tables S1-S2, Figures S1-S8 from Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity","display_name":"Supplementary Tables S1-S2, Figures S1-S8 from Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362619684","doi":"https://doi.org/10.1158/2767-9764.22545309"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.22545309","doi":"https://doi.org/10.1158/2767-9764.22545309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22545309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.22545309","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000853381","display_name":"Mahesh Raj Nepal","orcid":"https://orcid.org/0000-0001-7259-2699","observed_orcids":["https://orcid.org/0000-0001-7259-2699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahesh R. Nepal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067184440","display_name":"Hanieh Taheri","orcid":"https://orcid.org/0000-0003-3236-7870","observed_orcids":["https://orcid.org/0000-0003-3236-7870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanieh Taheri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100421368","display_name":"Yang Li","orcid":"https://orcid.org/0000-0001-9055-2332","observed_orcids":["https://orcid.org/0000-0001-9055-2332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9055-2332","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101783607","display_name":"Zahra Talebi","orcid":"https://orcid.org/0000-0001-9166-5160","observed_orcids":["https://orcid.org/0000-0001-9166-5160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zahra Talebi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046631238","display_name":"Muhammad Erfan Uddin","orcid":"https://orcid.org/0000-0002-7160-0455","observed_orcids":["https://orcid.org/0000-0002-7160-0455"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammad Erfan Uddin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7160-0455","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100411405","display_name":"Yan Jin","orcid":"https://orcid.org/0000-0002-7668-4803","observed_orcids":["https://orcid.org/0000-0002-7668-4803"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044512737","display_name":"Duncan F. DiGiacomo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Duncan F. DiGiacomo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068080699","display_name":"Alice A. Gibson","orcid":"https://orcid.org/0000-0001-5910-5067","observed_orcids":["https://orcid.org/0000-0001-5910-5067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice A. Gibson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5910-5067","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086903918","display_name":"Maryam B. Lustberg","orcid":"https://orcid.org/0000-0001-8559-5645","observed_orcids":["https://orcid.org/0000-0001-8559-5645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maryam B. Lustberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9806-7734","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2660-6644","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.048500001430511475,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.949999988079071},{"id":"https://openalex.org/keywords/oct2","display_name":"OCT2","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.8960000276565552},{"id":"https://openalex.org/keywords/peripheral-neurotoxicity","display_name":"peripheral neurotoxicity","score":0.9490000009536743},{"id":"https://openalex.org/keywords/amino-acid-transporters","display_name":"amino acid transporters","score":0.5730000138282776},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.718999981880188},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8059999942779541},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.5509999990463257},{"id":"https://openalex.org/keywords/anticancer-drug-toxicity","display_name":"anticancer drug toxicity","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.955331563949585},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.8371273279190063},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.6744027733802795},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.474710613489151},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4710274338722229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38644978404045105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3790479302406311},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.31570157408714294},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.20966923236846924},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1703164279460907},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1366300880908966},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.22545309","doi":"https://doi.org/10.1158/2767-9764.22545309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22545309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.22545309","doi":"https://doi.org/10.1158/2767-9764.22545309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22545309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296823104","https://openalex.org/W4362525447","https://openalex.org/W3017295529","https://openalex.org/W2052278699","https://openalex.org/W4281729275","https://openalex.org/W4206919709","https://openalex.org/W3175681497","https://openalex.org/W3029084204","https://openalex.org/W4225673949","https://openalex.org/W3182099117"],"abstract_inverted_index":{"Supplementary":[0,14,35,42,51,62,76,90,115,127],"Table":[1,15],"S1.":[2,37],"Percentage":[3],"of":[4,18,40,47,55,103,119,131],"OCT2":[5,60,68],"inhibition":[6],"by":[7,25,97],"compounds":[8],"reported":[9],"to":[10,29,73],"reduce":[11],"platinum-induced":[12],"toxicities.":[13],"S2.":[16,44],"Validation":[17],"human,":[19],"rat,":[20],"and":[21,88,109,135,139],"murine":[22],"overexpressed":[23],"cells":[24],"evaluating":[26],"their":[27],"ability":[28],"accumulate":[30],"known":[31],"prototypical":[32],"transport":[33],"substrates.":[34],"Figure":[36,43,52,63,77,91,116,128],"Chemical":[38],"structure":[39],"duloxetine.":[41],"IVIS":[45],"imaging":[46],"tumor":[48],"bearing":[49],"mice.":[50],"S3.":[53],"Metabolites":[54],"duloxetine":[56,132],"do":[57],"not":[58,81],"inhibit":[59],"function.":[61],"S4.":[64],"Duloxetine":[65,79],"is":[66],"an":[67],"inhibitor":[69],"that":[70],"extensively":[71],"binds":[72],"extracellular":[74],"membrane.":[75],"S5.":[78],"does":[80],"prevent":[82],"peripheral":[83],"neurotoxicity":[84],"associated":[85],"with":[86],"vincristine":[87],"paclitaxel.":[89],"S6.":[92],"Paw":[93],"withdrawal":[94],"force":[95],"measured":[96],"VFH":[98],"instrument":[99],"before":[100],"the":[101,104],"start":[102],"treatment":[105],"in":[106,121],"wild-type":[107],"(WT)":[108],"OCT1/2(-/-)":[110],"mice":[111],"(n=5-10":[112],"per":[113],"group).":[114],"S7.":[117],"Activity":[118],"oxaliplatin":[120],"various":[122],"colorectal":[123],"cancer":[124],"cell":[125],"lines.":[126],"S8.":[129],"Effect":[130],"on":[133],"sciatic":[134],"caudal":[136],"nerve":[137],"velocity":[138],"amplitude.":[140]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-07T00:00:00"}